Literature DB >> 1185861

Hormones in the treatment of metastatic renal cancer.

A Morales, G Kiruluta, S Lott.   

Abstract

Metastatic renal adenocarcinoma has been highly resistant to most therapeutic approaches. However, hormonal treatment has been reported to induce significant subjective or objective improvement. Two groups of patients receiving either androgens or progestogens were evaluated. The number of responses was disappointing. Furthermore, neither of the 2 regimens appeared to increase the mean surival between detection of metastases and fatal outcome.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1185861     DOI: 10.1016/s0022-5347(17)67119-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  2 in total

1.  [Prognosis of metastatic renal cell carcinoma related to the pattern of metastasis (author's transl)].

Authors:  B Bohnenkamp; W Rhomberg; W Sonnentag; U Feldmann
Journal:  J Cancer Res Clin Oncol       Date:  1980-01       Impact factor: 4.553

2.  Hormone receptors in renal cell carcinoma. Their utility as predictors of response to endocrine therapy.

Authors:  J Pearson; M A Friedman; P G Hoffman
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.